♟️ Friday 16 January 2026 Fri, 16 Jan 2026

Peako Limited has intensified its exploration efforts in the East Kimberley region, targeting multiple mineral commodities while implementing prudent cash flow measures including director remuneration deferrals.

Alice Queen Limited (AQX) has been suspended from ASX quotation due to its failure to adequately respond to regulatory queries, raising questions about its compliance status and future trading prospects.

Askari Metals has responded to an ASX query regarding an inadvertent breach of Listing Rule 10.11 after issuing securities to a related party without prior shareholder approval during a recent rights issue. The company outlines the circumstances and its planned remedial actions.

Cyprium Metals has secured $80 million in funding and advanced key infrastructure works to restart copper production at its Nifty Copper Complex, targeting first cathode output by mid-2026.

Zelira Therapeutics has raised nearly US$33 million from ThirdGate Capital to advance its HOPE® 1 drug targeting autism-related Phelan-McDermid Syndrome through FDA clinical trials. This funding milestone sets the stage for pivotal regulatory progress in the US.

Terra Critical Minerals has completed the acquisition of the True American Tungsten Project in Nevada, positioning itself to capitalise on soaring tungsten prices and supply constraints. The company plans extensive exploration in 2026 to validate and expand this historically high-grade asset.

Dalaroo Metals’ maiden sampling at Blue Lagoon reveals a district-scale critical minerals system with high-grade zirconium, hafnium, and rare earth elements over a 2.7km strike. The results validate historical data and position the project as a strategic asset in Greenland’s emerging critical minerals landscape.

IperionX has received the last $4.6 million tranche of a $47.1 million U.S. Department of War award and 290 metric tons of titanium scrap, advancing its plan to scale titanium production in Virginia.

Austral Resources Australia Ltd has agreed to acquire the Lady Loretta mine from Glencore for A$45.5 million, consolidating its copper assets near the Lady Annie Copper Mine and boosting its processing feedstock. This strategic move strengthens Austral’s balance sheet and advances its vision to become a mid-tier copper producer in Queensland.

Orthocell has increased its investment in Marine Biomedical to 11.7%, securing exclusive distribution rights to the innovative PearlBone™ technology as it nears FDA approval.

Ausgold Limited has delivered an updated Definitive Feasibility Study for its Katanning Gold Project, revealing increased gold production and enhanced financial returns, supported by a $90 million capital raise to accelerate development.

Australian Ethical reported a slight 1% decline in funds under management to $14.08 billion for December 2025, balancing positive retail flows against institutional mandate losses and market headwinds.

Lunnon Metals has completed a detailed Feasibility Study for its Lady Herial gold deposit, outlining a robust, short-life open pit mine with strong pre-tax cash flows exceeding $40 million. The project is fully permitted and poised for imminent development.

Talonx Resources has secured shareholder approval for two high-grade gold project acquisitions and extinguished $4.7 million in legacy debt, while completing drilling at its Viking Gold Project with assay results due soon.